All Type of News
Lifecord Co. to enter Chinese markets.
Lifecord, a bio medical company, made an intention of investment letter for $2 million of investment to SinoCells Bio Technologies Co., a stem cell research bio technology in Beijing.
At the same time, LifeCord r...
Workshop for Bio Chip Researchers on July 26.
The KFDA plans to hold a workshop for the bio-chip researchers at the Korea Health and Welfare Human Resource Development Institute on July 26 in order to advance the bio-chip commercialization.
Bio-chip is compri...
Korea Meditech exclusively to distribute an anti-allergic drug.
Vice president Kim Yeon-pan of Korea Meditech Co. made an exclusive distribution agreement for Oralgen, a novel anti-allergic drug, with Fornix Biosciences of Netherland on July 12.
Oralgen is a new immuno-therapeu...
Expo for atopy, allergy, asthma and skin care.
"The 3rd Atopy, Allergy, Asthma and Skin Care Exhibition" event will take place at Koex Pacific Hall for 4 days from Oct. 28 to 31 under the joint sponsorship of Korea Society of Exhibition Science and Korea Internati...
Daewon pushing more marketing efforts on Phenkini tab.
Daewon pharmaceutical company launched Phenkini (Phentermin Hcl 37.5mg), an appetite suppressant and Cafedrin tablet, a supplementation for the treatment of obesity.
The company said that Phenkini is an excellent w...
14 hospital labor union on strikes.
14 large general hospitals including Korea University hospital, Ewha and Hanyang University hospitals executed strikes after the failure of due negotiation between the labour union and the hospital management partners...
Pharmaceuticals produced at 1.34% out of GDP.
The total pharmaceutical production showed about 1.34% out of the GDP in 2004 according to the KPMA report titled "The pharmaceutical production ratio vs. other industries" in 2004.
The rates out of the GDP ...
Boryung to foster Astrix for a public healthcare drugBoryung has adopted a marketing strategy for "Astrix" (a drug for thrombosis) to be fostered as a public healthcare remedy. Astrix is a 100mg low dosed aspirin preparation for t...
|
KFDA approved additional indication for Wyeth Enbrel.
The KFDA approved Enbrel for the indication of ringworm in addition to its rheumatoid arthritis, especially for the patients who are moderate to severe ringwom diseases and resistant to other treatments as available. ...
KFDA to train new pharmaceutical related officials.
The KFDA conducted special training programs for 6 new officers responsible for the pharmaceutical affairs jobs focusing on their job practices in the class room located at 7th floor of KFDA office building starting f...
